3/ 31 mellem interferon og andre produkter, bør anden støttende behandling bruges forsigtigt og efter en grundig risiko/ effekt- analyse.
However, as specific information on possible interactions of interferon with other products are missing, supplementary supportive treatments should be used cautiously and after a thorough risk/ benefit analysis.